Search Results - "Rakaee, Mehrdad"

Cell-Targeted Inhibition of CaMK4 Suppresses Tertiary Lymphoid-like Structure Development in Lupus-Prone Mice.

Authors: Jamaly, Simin Rakaee, Mehrdad Ichinose, Kunihiro et al.

Source: International Journal of Molecular Sciences. Apr2026, Vol. 27 Issue 7, p3190. 9p.

Tissue analyses reveal a potential immune-adjuvant function of FAP-1 positive fibroblasts in non-small cell lung cancer.

Authors: Kilvaer, Thomas Karsten Rakaee, Mehrdad Hellevik, Turid et al.

Source: PLoS ONE. 2/7/2018, Vol. 13 Issue 2, p1-17. 17p.

Tertiary lymphoid structure score: a promising approach to refine the TNM staging in resected non-small cell lung cancer.

Authors: Rakaee, Mehrdad Kilvaer, Thomas K. Jamaly, Simin et al.

Source: British Journal of Cancer. May2021, Vol. 124 Issue 10, p1680-1689. 10p.

Prognostic Value of Macrophage Phenotypes in Resectable Non–Small Cell Lung Cancer Assessed by Multiplex Immunohistochemistry.

Authors: Rakaee, Mehrdad Busund, Lill-Tove Rasmussen Jamaly, Simin et al.

Source: Neoplasia. Mar2019, Vol. 21 Issue 3, p282-293. 12p.

Differential prognostic impact of platelet-derived growth factor receptor expression in NSCLC.

Authors: Kilvaer, Thomas Karsten Rakaee, Mehrdad Hellevik, Turid et al.

Source: Scientific Reports. 7/15/2019, Vol. 9 Issue 1, pN.PAG-N.PAG. 1p.

Interplay of immune and kidney resident cells in the formation of tertiary lymphoid structures in lupus nephritis.

Authors: Jamaly, Simin Rakaee, Mehrdad Abdi, Reza et al.

Source: Autoimmunity Reviews. Dec2021, Vol. 20 Issue 12, pN.PAG-N.PAG. 1p.

Expression of phosphatase of regenerating liver (PRL)-3, is independently associated with biochemical failure, clinical failure and death in prostate cancer.

Authors: Andersen, Sigve Richardsen, Elin Rakaee, Mehrdad et al.

Source: PLoS ONE. 11/30/2017, Vol. 12 Issue 11, p1-13. 13p.

Deep pathomics: A new image-based tool for predicting response to treatment in stage III non-small cell lung cancer.

Authors: Nibid, Lorenzo Greco, Carlo Cordelli, Ermanno et al.

Source: PLoS ONE. 11/28/2023, Vol. 18 Issue 11, p1-24. 24p.

Overexpression of miR-20a-5p in Tumor Epithelium Is an Independent Negative Prognostic Indicator in Prostate Cancer—A Multi-Institutional Study.

Authors: Stoen, Maria J. Andersen, Sigve Rakaee, Mehrdad et al.

Source: Cancers. Aug2021, Vol. 13 Issue 16, p4096. 1p.

Association of Baseline Tumor-Specific Neoantigens and CD8 + T-Cell Infiltration With Immune-Related Adverse Events Secondary to Immune Checkpoint Inhibitors.

Authors: Kerepesi, Csaba Abushukair, Hassan Mohammed Ricciuti, Biagio et al.

Source: JCO Precision Oncology. 12/1/2024, Vol. 8, p1-13. 13p.

CTLA-4 expression in the non-small cell lung cancer patient tumor microenvironment: diverging prognostic impact in primary tumors and lymph node metastases.

Authors: Paulsen, Erna-Elise Kilvaer, Thomas Rakaee, Mehrdad et al.

Source: Cancer Immunology, Immunotherapy. Nov2017, Vol. 66 Issue 11, p1449-1461. 13p.

Evaluation of the proliferation marker Ki-67 in a large prostatectomy cohort.

Authors: Richardsen, Elin Andersen, Sigve Al-Saad, Samer et al.

Source: PLoS ONE. 11/15/2017, Vol. 12 Issue 11, p1-13. 13p.

High expression of PDGFR-β in prostate cancer stroma is independently associated with clinical and biochemical prostate cancer recurrence.

Authors: Nordby, Yngve Richardsen, Elin Rakaee, Mehrdad et al.

Source: Scientific Reports. 2/24/2017, p43378. 1p.

Proteomic analyses identify major vault protein as a prognostic biomarker for fatal prostate cancer.

Authors: Ramberg, Håkon Richardsen, Elin Souza, Gustavo A de et al.

Source: Carcinogenesis. May2021, Vol. 42 Issue 5, p685-693. 9p.

Digitally quantified CD8⁺ cells: the best candidate marker for an immune cell score in non-small cell lung cancer?

Authors: Kilvaer, Thomas K Paulsen, Erna-Elise Andersen, Sigve et al.

Source: Carcinogenesis. Dec2020, Vol. 41 Issue 12, p1671-1681. 11p.

MicroRNA 141 is associated to outcome and aggressive tumor characteristics in prostate cancer.

Authors: Richardsen, Elin Andersen, Sigve Melbø-Jørgensen, Christian et al.

Source: Scientific Reports. 1/23/2019, Vol. 9 Issue 1, p1-1. 1p.

Enzyme-mediated depletion of methylthioadenosine restores T cell function in MTAP-deficient tumors and reverses immunotherapy resistance.

Authors: Gjuka, Donjeta Adib, Elio Garrison, Kendra et al.

Source: Cancer Cell. Oct2023, Vol. 41 Issue 10, p1774-1774. 1p.

DPP9-mediated inflammasome repression protects against checkpoint inhibitor lung toxicity.

Authors: Brewer JR Han A Nassar AH et al.

Source: BioRxiv : the preprint server for biology [bioRxiv] 2026 Jul 02. Date of Electronic Publication: 2026 Jul 02.

Publication Type: Journal Article; Preprint

Journal Info: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

Generalizability and Fairness in Deploying AI for Lung Cancer Biomarker Prediction-Reply.

Authors: Rakaee M Kwiatkowski DJ

Source: JAMA oncology [JAMA Oncol] 2026 Jul 01; Vol. 12 (7), pp. 789.

Publication Type: Journal Article

Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE; In Process

A myeloid immunosuppressive phenotype defines primary refractoriness to atezolizumab plus bevacizumab in hepatocellular carcinoma.

Authors: Lombardi P Ramon-Gil E Raja RQ et al.

Source: Journal of hepatology [J Hepatol] 2026 Jun 15. Date of Electronic Publication: 2026 Jun 15.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8503886 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0641 (Electronic) Linking ISSN: 01688278 NLM ISO Abbreviation: J Hepatol Subsets: MEDLINE